ArticleBMC structural biology2012

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.

Maria A Argiriadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.